LENZ THERAPEUTICS, INC. (LENZ)

Import this data to Google Sheets with:

=jivedata("LENZ","financials")

Full statements spill as a table. For one cell: =jivedata("LENZ","Revenue") or =jivedata("LENZ","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

LENZ THERAPEUTICS, INC.

LENZ • CIK 0001815776

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Operating Income (Loss)	$-135,191	$-58,610	$-91,138	$-135,657
Nonoperating Income (Expense)	$10,540	$8,842	$9,513	$9,660
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	—	$-49,768	$-81,625	$-125,997
Income Tax Expense (Benefit)	—	$1	$502	$5
Net Income (Loss) Attributable to Parent	$-124,651	$-49,769	$-82,127	$-126,002
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	—	$-49,579	$-82,081	$-126,669
Weighted Average Number of Shares Outstanding, Basic	57,015,159	21,281,038	28,813,164	32,372,618
Revenue from Contract with Customer, Excluding Assessed Tax	—	—	$19,088	$21,475
Cost of Goods and Services Sold	—	—	$418	$1,774
Selling, General and Administrative Expense	—	$28,809	$91,138	$151,567
Research and Development Expense	$32,137	$29,801	$18,670	$3,791
Costs and Expenses	—	—	$110,226	$157,132
Other Nonoperating Income (Expense)	$10,949	$289	$-243	$-441
Investment Income, Interest	—	$8,553	$9,756	$10,101
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax	$1,048	$190	$46	$-667

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$184,259	$20,158	$25,179	$24,208
DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	—	$188,872	$267,168	$195,795
Property, Plant and Equipment, Net	$0	$651	$1,189	$1,002
Accounts Receivable, after Allowance for Credit Loss, Current	—	—	$329	$442
Operating Lease, Right-of-Use Asset	$321	$1,338	$734	$521
Inventory, Net	—	—	$2,936	$4,121
Other Assets, Noncurrent	$0	$1,398	$2,541	$1,791
Prepaid Expense and Other Assets, Current	$2,160	$2,773	$5,800	$8,716
Assets	$188,456	$215,304	$305,876	$236,596
Restricted Cash, Current	$1,716	$114	$0	$0
Assets, Current	$188,021	$211,917	$301,412	$233,282
Operating Lease, Liability, Noncurrent	$77	$814	$350	$122
Liabilities	$4,874	$11,220	$21,537	$17,334
Accounts Payable, Current	$250	$4,257	$4,167	$6,648
Accrued Liabilities, Current	—	$6,149	$17,020	$9,779
Liabilities, Current	$4,797	$10,406	$21,187	$17,212
Preferred Stock, Value, Issued	$0	—	$0	$0
Common Stock, Value, Issued	$1	$1	$1	$1
Additional Paid in Capital	$550,635	$348,901	$511,237	$520,437
Retained Earnings (Accumulated Deficit)	$-367,054	$-145,014	$-227,141	$-300,547
Accumulated Other Comprehensive Income (Loss), Net of Tax	$0	$196	$242	$-629
Stockholders' Equity Attributable to Parent	$183,582	$204,084	$284,339	$219,262
Preferred Stock, Shares Authorized	10,000,000	—	10,000,000	10,000,000
Preferred Stock, Shares Issued	0	—	0	0
Common Stock, Shares Authorized	300,000,000	300,000,000	300,000,000	300,000,000
Common Stock, Shares, Issued	58,008,396	27,531,490	31,344,782	31,416,892
Common Stock, Shares, Outstanding	58,008,396	27,518,439	31,344,782	31,416,892

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$136,529	$-14,868	$4,907	$-13,514
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	—	$20,272	$25,179	$25,179
Net Income (Loss) Attributable to Parent	$-124,651	$-49,769	$-82,127	$-126,002
Net Cash Provided by (Used in) Operating Activities	$-90,007	$-59,391	$-69,170	$-113,908
Payments to Acquire Debt Securities, Available-for-sale	—	$241,911	$280,803	$212,848
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale	—	$87,900	$205,962	$190,131
Payments to Acquire Property, Plant, and Equipment	$10,856	$468	$827	$511
Net Cash Provided by (Used in) Investing Activities	$226,346	$-154,479	$-75,668	$-23,228
Proceeds from Issuance of Common Stock	—	$79,513	—	$26,126
Proceeds from Stock Options Exercised	$100	$4,038	$1,123	$897
Proceeds from Stock Plans	$157	—	$873	$1,043
Net Cash Provided by (Used in) Financing Activities	$190	$199,002	$149,745	$123,622
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	—	$1,116	$0	$0
Capital Expenditures Incurred but Not yet Paid	—	$203	$0	$-225
Depreciation, Depletion and Amortization	—	$58	$287	$453
Gain (Loss) on Disposition of Property Plant Equipment	—	$-16	$0	$0
Operating Lease, Impairment Loss	$46,900	—	$82	$0
Accretion (Amortization) of Discounts and Premiums, Investments	$-1,543	$4,017	$3,409	$1,834
Gain (Loss) on Investments	—	—	$-197	$-401
Fair Value Adjustment of Warrants	—	$1,047	$0	$0
Share-based Payment Arrangement, Noncash Expense	$10,574	$6,365	$12,547	$15,938
Increase (Decrease) in Accounts Receivable	—	—	$329	$442
Increase (Decrease) in Inventories	—	—	$4,275	$5,145
Increase (Decrease) in Prepaid Expense and Other Assets	$-5,676	$-25	$3,027	$4,747
Increase (Decrease) in Accounts Payable	$-2,358	$-4,279	$-90	$4,019
Increase (Decrease) in Accrued Liabilities	—	$-7,460	$10,975	$2,264
Increase (Decrease) in Other Noncurrent Assets	—	$1,377	$1	$-224

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("LENZ","financials")

Full statements spill as a table. For one cell: =jivedata("LENZ","Revenue") or =jivedata("LENZ","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.